NCT04767451 (POI&MICROs) is a clinical trial of ultrasound assessment in Premature Ovarian Failure, sponsored by Cengiz Gokcek Women's and Children's Hospital.

Who is sponsoring NCT04767451?

NCT04767451 is sponsored by Cengiz Gokcek Women's and Children's Hospital.

What drugs are being tested in NCT04767451?

Interventions in NCT04767451: ultrasound assessment.

What condition does NCT04767451 study?

NCT04767451 studies Premature Ovarian Failure.

Is NCT04767451 still recruiting?

NCT04767451 is currently status unknown. Last updated 31 August 2021.

Last reviewed 2021-08-31 · How we verify

NCT04767451: POI&MICROs

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Levels of Selected Microelements in Premature Ovarian Insufficiency

Status unknown Last updated 31 August 2021

What this trial tests

trial testing ultrasound assessment in Premature Ovarian Failure in 100 participants. Status unknown.

Timeline

25 February 2021

Primary endpoint
30 September 2021

30 October 2021

Quick facts

Lead sponsor	Cengiz Gokcek Women's and Children's Hospital
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	100
Start date	25 February 2021
Primary completion	30 September 2021
Estimated completion	30 October 2021
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

ultrasound assessment

Conditions studied

Premature Ovarian Failure — all drugs for Premature Ovarian Failure →

Sponsor

Cengiz Gokcek Women's and Children's Hospital

Who can join

Adults 18 to 39, female only, with Premature Ovarian Failure. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Aim: To evaluate plasma/urine/hair Lead (Pb), Cadmium (Cd), Gadolinium (Gd), Arsenic (As), Mercury (Hg), Cobalt (Co), Vanadium (V), Titanium (Ti), Sulfur (S), Chromium (Cr), Silver (Ag), Molybdenum (Mo), Boron (B), Lithium (Li), and Nickel (Ni) levels in women with premature ovarian insufficiency (POI) and to compare the results with those of healthy subjects. Methods: This prospective study will be included 50 women with idiopathic premature ovarian insufficiency and 50 controls. The blood/urine/hair for analyses will be obtained at the early follicular phase of the menstrual cycle and plasma Lead (Pb), Cadmium (Cd), Gadolinium (Gd), Arsenic (As), Mercury (Hg), Cobalt (Co), Vanadium (V), Titanium (Ti), Sulfur (S), Chromium (Cr), Silver (Ag), Molybdenum (Mo), Boron (B), Lithium (Li), and Nickel (Ni) levels will be measured using inductively coupled plasma-mass spectrometry.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of ultrasound assessment

Trials testing the same drug.

NCT05391282 — Internal Carotid Artery Blood Flow in Infants With Prone Position · unknown
NCT05185336 — Ultrasound Assessed Gastric Volume in the Fasted Pediatric Cerebral Palsy Patients · unknown
NCT04800705 — Levels of Selected Macroelements in Premature Ovarian Insufficiency · unknown
NCT04641624 — sFlt- 1, PIGF, and Niacin Levels in Women With Premature Ovarian Insufficiency · completed

Other recruiting trials for Premature Ovarian Failure

Currently open trials in the same condition.

NCT05740579 — The Danish TURNER Cryopreservation Study · NA · recruiting
NCT05462379 — Autologous Heterotopic Fresh Ovarian Graft in Woman With LACC Eligible for Pelvic Radiotherapy Treatment. · Phase 1, PHASE2 · active not recruiting
NCT04815213 — The Use of Expandeded Mesenchymal Stromal Cells (MSC) in Premature Ovarian Failure (POF) in Adult Humans · Phase 1 · active not recruiting
NCT04390308 — Is There A Role For Mechanical Stimulation In Ovarian Follicular Activation? · recruiting
NCT04381299 — Will Autologous Platelet Rich Plasma Able To Restore Ovarian Function? · active not recruiting

Other Cengiz Gokcek Women's and Children's Hospital trials

Trials by the same sponsor.

NCT04800705 — Levels of Selected Macroelements in Premature Ovarian Insufficiency · unknown
NCT04641624 — sFlt- 1, PIGF, and Niacin Levels in Women With Premature Ovarian Insufficiency · completed
NCT04588220 — Melatonin, Soluble Urokinase-type Plasminogen Activator Receptor, and Orosomucoid 2 Levels in PPROM · unknown
NCT04523233 — Metals/Vitamins Levels in NTD · unknown
NCT04532021 — Matrix Metalloproteinase 14, Neopterin, and Orosomucoid 1 Levels in PPROM · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04767451 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Cengiz Gokcek Women's and Children's Hospital
Last refreshed: 31 August 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04767451.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing